These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38959600)

  • 1. Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort.
    Lam C; Scaglia F; Berry GT; Larson A; Sarafoglou K; Andersson HC; Sklirou E; Tan QKG; Starosta RT; Sadek M; Wolfe L; Horikoshi S; Ali M; Barone R; Campbell T; Chang IJ; Coles K; Cook E; Eklund EA; Engelhardt NM; Freeman M; Friedman J; Fu DYT; Botzo G; Rawls B; Hernandez C; Johnsen C; Keller K; Kramer S; Kuschel B; Leshinski A; Martinez-Duncker I; Mazza GL; Mercimek-Andrews S; Miller BS; Muthusamy K; Neira J; Patterson MC; Pogorelc N; Powers LN; Ramey E; Reinhart M; Squire A; Thies J; Vockley J; Vreugdenhil H; Witters P; Youbi M; Zeighami A; Zemet R; Edmondson AC; Morava E
    Mol Genet Metab; 2024 Aug; 142(4):108509. PubMed ID: 38959600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
    Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
    Mol Genet Metab; 2024 Aug; 142(4):108513. PubMed ID: 38917675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation abnormalities and vascular complications are common in PGM1-CDG.
    Radenkovic S; Bleukx S; Engelhardt N; Eklund E; Mercimek-Andrews S; Edmondson AC; Morava E
    Mol Genet Metab; 2024 Aug; 142(4):108530. PubMed ID: 38968673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation.
    De Graef D; Ligezka AN; Rezents J; Mazza GL; Preston G; Schwartz K; Krzysciak W; Lam C; Edmondson AC; Johnsen C; Kozicz T; Morava E
    Mol Genet Metab; 2023 Jun; 139(2):107606. PubMed ID: 37224763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes and quality of life in PMM2-CDG.
    Ligezka AN; Mohamed A; Pascoal C; Ferreira VDR; Boyer S; Lam C; Edmondson A; Krzysciak W; Golebiowski R; Perez-Ortiz J; Morava E
    Mol Genet Metab; 2022 Jun; 136(2):145-151. PubMed ID: 35491370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Phenotype Correlations in PMM2-CDG.
    Vaes L; Rymen D; Cassiman D; Ligezka A; Vanhoutvin N; Quelhas D; Morava E; Witters P
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSR4-CDG, an ultra-rare X-linked congenital disorder of glycosylation affecting the TRAP complex: Review of 22 affected individuals including the first adult patient.
    Johnsen C; Tabatadze N; Radenkovic S; Botzo G; Kuschel B; Melikishvili G; Morava E
    Mol Genet Metab; 2024 Jul; 142(3):108477. PubMed ID: 38805916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
    Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
    Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
    Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
    Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications.
    Ligezka AN; Radenkovic S; Saraswat M; Garapati K; Ranatunga W; Krzysciak W; Yanaihara H; Preston G; Brucker W; McGovern RM; Reid JM; Cassiman D; Muthusamy K; Johnsen C; Mercimek-Andrews S; Larson A; Lam C; Edmondson AC; Ghesquière B; Witters P; Raymond K; Oglesbee D; Pandey A; Perlstein EO; Kozicz T; Morava E
    Ann Neurol; 2021 Dec; 90(6):887-900. PubMed ID: 34652821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital Disorders of Glycosylation in Portugal-Two Decades of Experience.
    Quelhas D; Martins E; Azevedo L; Bandeira A; Diogo L; Garcia P; Sequeira S; Ferreira AC; Teles EL; Rodrigues E; Fortuna AM; Mendonça C; Fernandes HC; Medeira A; Gaspar A; Janeiro P; Oliveira A; Laranjeira F; Ribeiro I; Souche E; Race V; Keldermans L; Matthijs G; Jaeken J
    J Pediatr; 2021 Apr; 231():148-156. PubMed ID: 33340551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions.
    Muthusamy K; Perez-Ortiz JM; Ligezka AN; Altassan R; Johnsen C; Schultz MJ; Patterson MC; Morava E
    Genet Med; 2024 Feb; 26(2):101027. PubMed ID: 37955240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAN1B1-CDG: novel patients and novel variant.
    Kasapkara CS; Olgac A; Kilic M; Keldermans L; Matthijs G; Jaeken J
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1207-1209. PubMed ID: 34162022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental profiles of 14 individuals with phosphomannomutase deficiency (PMM2-CDG).
    Weixel T; Adedipe D; Muldoon G; Lam C; Krasnewich D; Thurm A; Wolfe L
    J Inherit Metab Dis; 2024 Aug; ():. PubMed ID: 39105373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype.
    Elsharkawi I; Wongkittichote P; Daniel EJP; Starosta RT; Ueda K; Ng BG; Freeze HH; He M; Shinawi M
    J Inherit Metab Dis; 2023 Jan; 46(1):92-100. PubMed ID: 36214423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.
    Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L
    Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes in ALG13-Congenital Disorder of Glycosylation.
    Shah R; Johnsen C; Pletcher BA; Edmondson AC; Kozicz T; Morava E
    Am J Med Genet A; 2023 Jun; 191(6):1626-1631. PubMed ID: 36930724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.